Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tibor Major

Showing results (101-110 of 174) with videos related to

Pageof 18
Sort By:
Ideggyogyaszati Szemle|November 12, 2003
[Image-fusion-guided radioisotope I-125 stereotactic brachytherapy of acoustic neurinoma--new surgical method]Arpád Viola, Tibor Major, István Valálik, et al.
Brachytherapy|February 25, 2011
Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patientsPéter Agoston, Tibor Major, Georgina Fröhlich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 26, 2010
Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical studyCsaba Polgár, Tibor Major, János Fodor, et al.
Magyar Onkologia|March 20, 2019
[Stereotactic body radiation therapy with CyberKnife accelerator for low- and intermediate risk prostate cancer]Kliton Jorgo, Péter Ágoston, Levente Jánváry, et al.
Orvosi Hetilap|March 22, 2003
[Interstitial boost and altered fractionation as novel approaches to dose escalation in the radiotherapy of glioblastoma multiforme]László Mangel, Jenö Julow, Tibor Major, et al.
Pathology Oncology Research : POR|March 20, 2019
Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective StudyKliton Jorgo, Csaba Polgar, Tibor Major, et al.
Brachytherapy|March 21, 2019
Second breast-conserving surgery and interstitial brachytherapy vs. salvage mastectomy for the treatment of local recurrences: 5-year resultsViktor Smanykó, Norbert Mészáros, Mihály Újhelyi, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 7, 2026
Risk estimations of radiation induced malignancies in rectum and bladder following radiotherapy of prostate carcinomaBrigitta Timea Herczeg, Ákos Sudár, Rita Ortutay, et al.
Magyar Onkologia|June 3, 2015
[Imaging protocols for the management of respiratory motions in the radiotherapy planning for early stage lung cancer patients]Tamás Pócza, Csilla Pesznyák, József Lövey, et al.
Magyar Onkologia|June 3, 2015
[Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy]András Herein, Péter Ágoston, Zoltán Szabó, et al.
Pageof 18

Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
Ideggyogyaszati Szemle|November 12, 2003
[Image-fusion-guided radioisotope I-125 stereotactic brachytherapy of acoustic neurinoma--new surgical method]Arpád Viola, Tibor Major, István Valálik, et al.
Brachytherapy|February 25, 2011
Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patientsPéter Agoston, Tibor Major, Georgina Fröhlich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 26, 2010
Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical studyCsaba Polgár, Tibor Major, János Fodor, et al.
Magyar Onkologia|March 20, 2019
[Stereotactic body radiation therapy with CyberKnife accelerator for low- and intermediate risk prostate cancer]Kliton Jorgo, Péter Ágoston, Levente Jánváry, et al.
Orvosi Hetilap|March 22, 2003
[Interstitial boost and altered fractionation as novel approaches to dose escalation in the radiotherapy of glioblastoma multiforme]László Mangel, Jenö Julow, Tibor Major, et al.
Pathology Oncology Research : POR|March 20, 2019
Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective StudyKliton Jorgo, Csaba Polgar, Tibor Major, et al.
Brachytherapy|March 21, 2019
Second breast-conserving surgery and interstitial brachytherapy vs. salvage mastectomy for the treatment of local recurrences: 5-year resultsViktor Smanykó, Norbert Mészáros, Mihály Újhelyi, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 7, 2026
Risk estimations of radiation induced malignancies in rectum and bladder following radiotherapy of prostate carcinomaBrigitta Timea Herczeg, Ákos Sudár, Rita Ortutay, et al.
Magyar Onkologia|June 3, 2015
[Imaging protocols for the management of respiratory motions in the radiotherapy planning for early stage lung cancer patients]Tamás Pócza, Csilla Pesznyák, József Lövey, et al.
Magyar Onkologia|June 3, 2015
[Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy]András Herein, Péter Ágoston, Zoltán Szabó, et al.
Pageof 18